Life Sciences

The mission of HS Life Sciences is to provide a forum to review and discuss what is now possible in the industry.

Welcome to HS Life Sciences
Menu Links
Path
contact-us
Link text
Contact Us
Path
about-us
Link text
About Us
Path
courses
Link text
Events
Footer Banner
Footer Contact Us

CONTACT US
Ruskin House, 40-41 Museum Street, London WC1A 1LT, UK

Footer Copyright Notice

Henry Stewart Conference Studies LLP is a limited liability partnership, registered in England, registration number OC334769 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events Ltd is a limited company, registered in England, registration number 06532399 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events, Inc. is a corporation incorporated in the State of Delaware, USA having a business office at PKF O’Connor Davies LLP, 665 Fifth Avenue, New York NY 10022.
© Henry Stewart Conference Studies LLP or its affiliates.

Display Name
HS Life Sciences
Banner Image

Life Sciences Speaker Tony O'Hagan

Professor Anthony O'Hagan is an Emeritus Professor of Statistics at the University of Sheffield, UK.  A major strand of his research has been the elicitation of expert knowledge.  With Professor Jeremy Oakley (University of Sheffield), he developed the Sheffield Elicitation Framework (SHELF), now in version 4.  He has provided consultancy, training, and practical elicitations for several organisations in diverse sectors, including GlaxoSmithKline, Swiss Re and the European Food Safety Authority.

Life Sciences Applying SHELF in the Pharmaceutical and Biotech Industry

An introductory course for those new to expert elicitation

 

The earlier you can stop development of a therapeutic intervention that will not make it all the way to the clinic the better. Getting that call right is the challenge - but increasing the chances of making the right call is one of the greatest contributions teams can make to reducing costs and increasing profits.

Life Sciences Hub Speaker Jim McNally

Dr. McNally has an extensive background in bioanalytical assay development and program leadership spanning nearly 20 years working in the pharmaceutical and biotechnology industry.

Life Sciences Hub Speaker Claire Bonal

After completing her MD PhD at the University of Geneva Medical School, Claire did a postdoctoral fellowship at Harvard University studying key regulators of pancreatic beta cell development and regeneration. In 2010, Claire transitioned to industry joining Merrimack Pharmaceuticals in Cambridge, MA to advance their anti-EGFR program in oncology. In 2013, Claire joined Novartis leading the cross-functional team for Switzerland developing strategic imperatives in development, medical affairs, market access and commercial strategy with a focus on orphan drugs in rare diseases.

Life Sciences Hub Speaker Professor Marc Pallardy

Marc Pallardy, Pharm D 1982, PhD in Toxicology 1987, Full professor and Head of the Department of Toxicology (Faculty of Pharmacy, University of Paris-Saclay) since 1997.  Marc is currently Dean of the Faculty of Pharmacy, University Paris-Saclay (since 2015) and Head of the Team 2 “Drug and Chemical Allergy, Immunotoxicology and Immunopathology”, INSERM UMR 996.

Life Sciences Speaker Hannah Morgan

As a Senior Principal Scientist in the translational immunology group in pre-clinical safety (PCS) Dr. Hannah Morgan is a specialist in the in vitro assessment of biotherapeutic-induced immune related adverse events with a particular focus on immunogenicity.

Life Sciences Speaker Jim McNally

Dr. McNally has an extensive background in bioanalytical assay development and program leadership spanning nearly 20 years working in the pharmaceutical and biotechnology industry.

Life Sciences